(RGLS) Regulus Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Regulus Therapeutics | (RGLS) share price targets
Complete technical analysis of Regulus Therapeutics (RGLS) by charts plus indicators, forecast predictions and share price targets for Regulus Therapeutics (RGLS)
Regulus Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-05-21 View latest technical analysis
10 day averaged volume of Regulus Therapeutics is 1015740
| Date | Daily Closing Price | Open | High | Low | Volume |
| 21 Wed May 2025 | 7.92 | 7.91 | 7.98 | 7.88 | 0.701 times |
| 20 Tue May 2025 | 7.95 | 7.85 | 7.97 | 7.85 | 0.684 times |
| 19 Mon May 2025 | 7.87 | 7.84 | 7.88 | 7.83 | 1.015 times |
| 16 Fri May 2025 | 7.87 | 7.85 | 7.88 | 7.84 | 0.847 times |
| 15 Thu May 2025 | 7.85 | 7.84 | 7.86 | 7.83 | 0.757 times |
| 14 Wed May 2025 | 7.84 | 7.85 | 7.89 | 7.84 | 1.036 times |
| 13 Tue May 2025 | 7.84 | 7.85 | 7.90 | 7.84 | 1.398 times |
| 12 Mon May 2025 | 7.87 | 7.86 | 7.90 | 7.82 | 0.999 times |
| 09 Fri May 2025 | 7.87 | 7.83 | 7.92 | 7.81 | 1.62 times |
| 08 Thu May 2025 | 7.85 | 7.84 | 7.86 | 7.83 | 0.685 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 8.8 as stoploss in an intra day sell trade for a target of 6.92. However, stock will show a bullish move above 8.8.
Share price targets for Regulus Therapeutics (RGLS)
| Target Type | Value |
| Downside Target | 0.83 |
| Downside Target | 1.01 |
| Downside Target | 1.22 |
| Downside Target | 1.52 |
| Downside Target | 1.60 |
| Downside Target | 1.64 |
| Downside Target | 1.84 |
| Downside Target | 1.98 |
| Downside Target | 2.76 |
| Downside Target | 2.90 |
| Downside Target | 7.74 |
| Upside Target | 7.98 |
| Upside Target | 8.20 |
Intraday share price targets for Regulus Therapeutics (RGLS)
| Target Type | Value |
| Downside Intraday Target | 7.84 |
| Downside Intraday Target | 7.76 |
| Upside Intraday Target | 7.99 |
| Upside Intraday Target | 8.06 |
| Downside Intraday Target | 7.91 |
Weekly technical analysis of Regulus Therapeutics (RGLS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 21 Wed May 2025 | 7.92 | 7.84 | 7.98 | 7.83 | 0.476 times |
| 16 Fri May 2025 | 7.87 | 7.86 | 7.90 | 7.82 | 0.901 times |
| 09 Fri May 2025 | 7.87 | 7.83 | 7.92 | 7.80 | 0.128 times |
| 02 Fri May 2025 | 7.85 | 2.78 | 8.20 | 2.76 | 9.11 times |
| 25 Fri Apr 2025 | 2.76 | 2.09 | 2.90 | 1.98 | 3.679 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Regulus Therapeutics (RGLS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 21 Wed May 2025 | 7.92 | 7.84 | 7.98 | 7.74 | 0.417 times |
| 30 Wed Apr 2025 | 7.98 | 1.71 | 8.20 | 1.52 | 5.425 times |
| 31 Mon Mar 2025 | 1.75 | 1.38 | 1.84 | 1.22 | 0.953 times |
| 28 Fri Feb 2025 | 1.35 | 1.05 | 1.60 | 1.01 | 0.811 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Regulus Therapeutics (RGLS)
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Regulus Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Regulus Therapeutics in short term but the sell signal is initial and weak.
Regulus Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Regulus Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Regulus Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.87 and Regulus Therapeutics (RGLS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Regulus Therapeutics (RGLS) stock. Volume based technical analysis of Regulus Therapeutics (RGLS) stock is negative.
Regulus Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Regulus Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Regulus Therapeutics in short term but the sell signal is initial and weak.
Regulus Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Regulus Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Regulus Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.87 and Regulus Therapeutics (RGLS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Regulus Therapeutics (RGLS) stock. Volume based technical analysis of Regulus Therapeutics (RGLS) stock is negative.
Regulus Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.